Gene cloning and overproduction of low-specificity D-threonine aldolase from Alcaligenes xylosoxidans and its application for production of a key intermediate for parkinsonism drug
Jq. Liu et al., Gene cloning and overproduction of low-specificity D-threonine aldolase from Alcaligenes xylosoxidans and its application for production of a key intermediate for parkinsonism drug, APPL MICR B, 54(1), 2000, pp. 44-51
The dtaAX gene encoding a pyridoxal 5'-phosphate (pyridoxal-P)-dependent lo
w-specificity D-threonine aldolase was cloned from the chromosomal DNA of A
lcaligenes xylosoxidans IFO 12669. It contains an open reading frame consis
ting of 1,134 nucleotides corresponding to 377 amino acid residues. The pre
dicted amino acid sequence displayed 54% identity with that of D-threonine
aldolase from gram-positive bacteria Ar-throbacter sp. DK-38, but showed no
significant similarity with those of other known pyridoxal-P enzymes. This
gram-negative bacterial enzyme was highly overproduced in recombinant Esch
erickia coli cells, and the specific activity of the enzyme in the cell ext
ract was as high as 18 U/mg (purified enzyme 38.6 U/mg), which was 6,000 ti
mes higher than that from the wild-type Alcaligenes cell extract. The recom
binant enzyme was thus feasibly purified to homogeneity by ammonium sulfate
fractionation and DEAE-Toyopearl chromatography steps. The recombinant low
-specificity D-threonine aldolase was shown to be an efficient biocatalyst
for resolution of L-beta-3,4-methylenedioxyphenylserine, an intermediate fo
r production of a therapeutic drug for Parkinson's disease.